Wolverine Trading, LLC Bluebird Bio, Inc. Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

25 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$0.91 - $1.75 $19,656 - $37,800	-21,600 Reduced 46.15%	25,200 $32,000
Q4 2023 Feb 14, 2024	BUY	$1.32 - $4.83 $31,548 - $115,437	23,900 Added 104.37%	46,800 $64,000
Q3 2023 Nov 15, 2023	BUY	$3.02 - $4.05 $16,912 - $22,680	5,600 Added 32.37%	22,900 $69,000
Q2 2023 Aug 23, 2023	SELL	$2.79 - $5.03 $17,019 - $30,683	-6,100 Reduced 26.07%	17,300 $56,000
Q1 2023 May 15, 2023	SELL	$3.14 - $8.22 $21,038 - $55,074	-6,700 Reduced 22.26%	23,400 $73,000
Q4 2022 Feb 14, 2023	SELL	$5.77 - $8.49 $26,541 - $39,054	-4,600 Reduced 13.26%	30,100 $208,000
Q3 2022 Nov 14, 2022	BUY	$3.75 - $7.39 $130,125 - $256,433	34,700 New	34,700 $198,000
Q2 2022 Aug 15, 2022	SELL	$2.94 - $5.23 $112,308 - $199,786	-38,200 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.07 - $10.6 $155,474 - $404,920	38,200 New	38,200 $188,000
Q4 2021 Feb 14, 2022	SELL	$8.96 - $16.31 $163,072 - $296,842	-18,200 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$11.24 - $21.0 $128,136 - $239,400	-11,400 Reduced 38.51%	18,200 $345,000
Q2 2021 Aug 06, 2021	SELL	$18.04 - $22.09 $335,544 - $410,874	-18,600 Reduced 38.59%	29,600 $890,000
Q1 2021 May 14, 2021	BUY	$16.59 - $33.89 $504,336 - $1.03 Million	30,400 Added 170.79%	48,200 $1.38 Million
Q4 2020 Feb 12, 2021	SELL	$27.5 - $37.92 $170,500 - $235,104	-6,200 Reduced 25.83%	17,800 $785,000
Q3 2020 Nov 13, 2020	SELL	$34.44 - $43.75 $268,632 - $341,250	-7,800 Reduced 24.53%	24,000 $1.32 Million
Q2 2020 Aug 13, 2020	BUY	$27.12 - $45.97 $132,888 - $225,253	4,900 Added 18.22%	31,800 $1.91 Million
Q1 2020 May 11, 2020	SELL	$26.16 - $63.5 $172,656 - $419,100	-6,600 Reduced 19.7%	26,900 $1.26 Million
Q4 2019 Feb 12, 2020	SELL	$46.96 - $61.67 $14,088 - $18,501	-300 Reduced 0.89%	33,500 $2.93 Million
Q3 2019 Nov 14, 2019	SELL	$59.47 - $93.1 $927,732 - $1.45 Million	-15,600 Reduced 31.58%	33,800 $3.14 Million
Q2 2019 Aug 20, 2019	BUY	$75.84 - $105.21 $3.75 Million - $5.2 Million	49,400 New	49,400 $6.28 Million
Q4 2018 Feb 14, 2019	SELL	$59.1 - $93.26 $4.29 Million - $6.77 Million	-72,600 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$88.86 - $117.49 $2.35 Million - $3.11 Million	26,500 Added 57.48%	72,600 $10.6 Million
Q1 2018 May 15, 2018	SELL	$105.8 - $150.94 $1.44 Million - $2.05 Million	-13,600 Reduced 22.78%	46,100 $7.87 Million
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $2.31 Million - $3.71 Million	28,400 Added 90.73%	59,700 $10.6 Million
Q3 2017 Nov 15, 2017	BUY	$57.74 - $91.42 $1.81 Million - $2.86 Million	31,300	31,300 $4.3 Million

Others Institutions Holding BLUE

# of Institutions

150

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$131 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$89 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$39.8 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$39.7 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$32.7 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $656M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account